Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Genetics ; 185(1): 245-55, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20194968

RESUMO

The waved with open eyes (woe) locus is a spontaneous recessive mouse mutation that exhibits wavy fur, eyelids open at birth, and enlarged heart and esophagus. In this study, we confirmed the previously identified woe phenotypes and additionally identified anterior eye segment defects, absence of the meibomian glands, and defects in the semilunar cardiac valves. Positional cloning identified a C794T substitution in the Adam17 gene that ablates a putative exonic splicing enhancer (ESE) sequence in exon 7 resulting in aberrant Adam17 splicing. The predominant woe transcript, Adam17(Delta)(exon7), lacks exon 7 resulting in an in-frame deletion of 90 bp and a putative Adam17(Delta252-281) protein lacking residues 252-281 from the metalloprotease domain. Western blot analysis in woe identified only the precursor form of Adam17(Delta252-281) protein. Absence of cleavage of the prodomain renders Adam17(Delta252-281) functionally inactive; however, constitutive and stimulated shedding of Adam17 substrates was detected in woe at significantly reduced levels. This residual Adam17 shedding activity in woe most likely originates from full-length Adam17(T265M) encoded by the Adam17(C794T) transcript identified expressed at severely reduced levels. These results show that even small amounts of functional Adam17 allow woe mice to survive into adulthood. In contrast to Adam17(-/-) mice that die at birth, the viability of woe mice provides an excellent opportunity for studying the role of Adam17 throughout postnatal development and homeostasis.


Assuntos
Proteínas ADAM/genética , Loci Gênicos/genética , Mutação/genética , Proteínas ADAM/química , Proteína ADAM17 , Alelos , Processamento Alternativo/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , Embrião de Mamíferos/citologia , Olho/metabolismo , Olho/patologia , Fibroblastos/metabolismo , Camundongos , Dados de Sequência Molecular , Miocárdio/metabolismo , Miocárdio/patologia , Fenótipo
2.
Blood ; 86(2): 636-45, 1995 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-7605993

RESUMO

We identified a dog with large granular lymphocytic leukemia and cutaneous lymphoma that exhibited constitutive expression of interleukin-2 (IL-2) receptors by the leukemic peripheral blood lymphocytes. The leukemic cells phenotypically resembled natural killer (NK) cells, and their surface IL-2 receptors were functional, as determined by the capacity to bind human recombinant IL-2 with high-affinity resulting in the transduction of proliferation signals and in the development of lymphokine-activated killer cell activity. These cells produced IL-2 spontaneously, and they may have maintained their proliferative state through an IL-2-dependent autocrine growth pathway. Our results indicate that neoplastic lymphocytes of syndromes that involve circulating leukemic cells with dermotropism can originate from NK-like cells. Additionally, the data also suggest that proliferative conditions such as these may be the result of the aberrant production of IL-2. Further, this case illustrates the potential for the use of hematopoietic malignancies in the dog as a suitable animal model for immune targeting of IL-2 receptors as a novel treatment approach for similar malignancies of human beings.


Assuntos
Doenças do Cão/imunologia , Células Matadoras Naturais/patologia , Linfoma Difuso de Grandes Células B/veterinária , Transtornos Linfoproliferativos/veterinária , Proteínas de Neoplasias/análise , Células-Tronco Neoplásicas/química , Receptores de Interleucina-2/análise , Neoplasias Cutâneas/veterinária , Animais , Citotoxicidade Imunológica , Cães , Feminino , Humanos , Imunofenotipagem , Interleucina-2/metabolismo , Células Matadoras Naturais/imunologia , Linfoma Difuso de Grandes Células B/imunologia , Linfoma Difuso de Grandes Células B/patologia , Transtornos Linfoproliferativos/imunologia , Transtornos Linfoproliferativos/patologia , Proteínas de Neoplasias/metabolismo , Células-Tronco Neoplásicas/imunologia , Células-Tronco Neoplásicas/patologia , Receptores de Interleucina-2/metabolismo , Proteínas Recombinantes/metabolismo , Neoplasias Cutâneas/imunologia , Neoplasias Cutâneas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA